JAK-IN-14
JAK-IN-14 is a potent and selective JAK1 inhibitor, with an IC50 of 8-fold more selective for JAK1 than JAK2 and JAK3 (Patent WO2016119700A1, compound 16) [1].
Product Specifications
CAS Number
[1973485-06-1]
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jak-in-14.html
Concentration
10mM
Purity
99.15
Solubility
DMSO : 10.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
N#CCC1=CC(F)=C(C2=CC=CC3=NC(NC(C4CC4)=O)=CN32)C=C1
Molecular Formula
C19H15FN4O
Molecular Weight
334.35
References & Citations
[1]Jin Li, et al. Substituted imidazo [1, 2-a] pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof. WO2016119700A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
32-8109-50 50 µg
Recombinant Human Microtubule-Associated Protein 1 Light Chain 3 a/MAP1LC3A (C-6His)
Ask
View Details 
128250-FITC 100 µL
IFIT3 (Interferon-induced Protein with Tetratricopeptide Repeats 3, IFIT-3, CIG49, ISG-60, Interferon-induced 60kD Protein, IFI-60K, Interferon-induced Protein with Tetratricopeptide Repeats 4, IFIT-4, Retinoic Acid-induced Gene G-Protein, P60, RIG-G, CIG-49, IFI60, IFIT4, ISG60) (FITC)
Ask
View Details 
FY-AB34629-01 1 mL
Anti-Tissue Inhibitors Of Metalloproteinase 2 (TIMP2) Polyclonal antibody
Ask
View Details